1st Edition

Silver Nanoparticles for Antibacterial Devices
Biocompatibility and Toxicity

Edited By

Huiliang Cao

ISBN 9781498725323
Published May 25, 2017 by CRC Press
478 Pages 32 Color & 94 B/W Illustrations

USD $270.00

Prices & shipping based on shipping country


Book Description

Since the potential toxicity of silver nanoparticles (Ag NPs) has raised serious concerns in the biomaterials and biomedical engineering community, Silver Nanoparticles for Antibacterial Devices: Biocompatibility and Toxicity brings together the synthesis, the physicochemical properties and the biological actions of Ag NPs, as well as the clinical demands for fabricating antibacterial medical devices, discussing how to suppress the side effects of nanomaterials and how to impart to them the selective toxicity. This book presents the two primary paradigms that have emerged in probing the antibacterial applications of Ag NPs, i.e. the active attacking releasing way and the conservative defending approach by taking advantage of various short-range actions; it shows readers how the ways in which Ag NPs have behaved can be engineered purposively.

With contributions from leading international experts and extensive references listed in each chapter, this volume provides the general principles on controlling the physicochemical behaviors of nanomaterials and managing their toxicity risks.

Table of Contents

SECTION I: Synthesis and Assembling

Chapter 1: Bioinspired Synthesis of Silver Nanoparticles: Characterization, Mechanism and Applications

Chapter 2: Tuning the Properties of Silver Monolayer for Biological Applications

Chapter 3: Synergistic Antimicrobial Activity of Silver and Chitosan

Chapter 4: Titania Nanotubes as Silver Nanoparticle Carriers to Prevent Implant-associated Infection

Chapter 5: Polymer-silver Nanocomposites: Preparation, Characterization and Antibacterial Mechanism


SECTION II: The Risk of Silver

Chapter 6: Dissolution of Silver Nanoparticles

Chapter 7: Silver as an antimicrobial agent: the Resistance Issue

Chapter 8: The Risks of Silver Nanoparticles to Human Body

Chapter 9: Imunomodulatory Activities of Silver nanoparticles (Ag NPs) in Human Neutrophils


SECTION III: Techniques and Concepts for Risk Control

Chapter 10: Evaluating the Interactions of Silver Nanoparticles and Mammalian Cells Based on Biomices Technologies

Chapter 11: Methods and Tools for Assessing Nanomaterials and Uses and Regulation of Nanosilver in Europe

Chapter 12: Toward Selectively Toxic Silver Nanoparticles


SECTION IV: Clinical Demands

Chapter 13: Orthopaedic Implant-associated Infections: Pathogenesis, Clinical Presentation and Management

Chapter 14: Dental Implant Infection: Typical Causes and Control

Chapter 15: Guidelines for Nanosilver-based Antibacterial Devices

View More

Featured Author Profiles

Author - Huiliang  Cao

Huiliang Cao

Dr., Shanghai Institute of Ceramics, Chinese Academy of Sciences

Learn more about Huiliang Cao »